Literature DB >> 6234475

Bicaudate diameter--the most specific and simple CT parameter in the diagnosis of Huntington's disease.

T Stober, W Wussow, K Schimrigk.   

Abstract

In addition to the neurological findings, the functional capacity of 12 patients with Huntington's disease was evaluated quantitatively according to the Shoulson and Fahn scale [1]. This parameter was related to the following computed tomographic measurements: the greatest distance between the frontal horns (FH), the shortest distance between the heads of the caudate nuclei (bicaudate diameter, CC) and the quotient FH/CC. The ratio of the bicaudate diameter and the external diameter of the skull across the narrowest point of the heads of the caudate nuclei (CC/OTcc) was also used as well as the bicaudate diameter and the maximum internal diameter of the skull (CC/ITmax). The best correlation was found between the bicaudate diameter and functional capacity (r = -0.64, P less than 0.05). All the quotients containing the bicaudate diameter likewise showed a correlation with functional capacity, though to a less marked degree. Thus the bicaudate diameter appears to be the most specific and simple computed tomographic parameter for the differentiation of Huntington's disease from normal states or choreatic syndromes of different origin.

Entities:  

Mesh:

Year:  1984        PMID: 6234475     DOI: 10.1007/bf00328198

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  8 in total

1.  Huntington disease: clinical care and evaluation.

Authors:  I Shoulson; S Fahn
Journal:  Neurology       Date:  1979-01       Impact factor: 9.910

2.  Bicaudate index in computerized tomography of Huntington disease and cerebral atrophy.

Authors:  A N Barr; W J Heinze; G D Dobben; G E Valvassori; O Sugar
Journal:  Neurology       Date:  1978-11       Impact factor: 9.910

3.  Computed tomography for Huntington's disease.

Authors:  C F Terrence; J F Delaney; M C Alberts
Journal:  Neuroradiology       Date:  1977-06-27       Impact factor: 2.804

4.  Diagnostic value of CT in patients with Huntington's chorea and their offspring.

Authors:  G Oepen; C Ostertag
Journal:  J Neurol       Date:  1981       Impact factor: 4.849

5.  Huntington disease: functional capacities in patients treated with neuroleptic and antidepressant drugs.

Authors:  I Shoulson
Journal:  Neurology       Date:  1981-10       Impact factor: 9.910

6.  The Evans ratio for ventricular size: a calculation error.

Authors:  L M Zatz
Journal:  Neuroradiology       Date:  1979-08-15       Impact factor: 2.804

7.  Frontal ventricular dimensions on normal computed tomography.

Authors:  F J Hahn; K Rim
Journal:  AJR Am J Roentgenol       Date:  1976-03       Impact factor: 3.959

8.  Morphometric studies of the neuropathological changes in choreatic diseases.

Authors:  H Lange; G Thörner; A Hopf; K F Schröder
Journal:  J Neurol Sci       Date:  1976-08       Impact factor: 3.181

  8 in total
  10 in total

1.  Measurement of caudate nucleus area--a more accurate measurement for Huntington's disease?

Authors:  J M Wardlaw; R J Sellar; L J Abernethy
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

2.  Computerized tomography in amyotrophic choreo-acanthocytosis.

Authors:  S Serra; A Xerra; E Scribano; M Meduri; R Di Perri
Journal:  Neuroradiology       Date:  1987       Impact factor: 2.804

3.  Huntington's disease in two unrelated Arab kindreds and in an Afghani family resident in Saudi Arabia.

Authors:  E M Scrimgeour; S A Tahoon; T H Zawawi
Journal:  J Med Genet       Date:  1994-10       Impact factor: 6.318

4.  Huntington's disease: a molecular genetic and CT comparison.

Authors:  P Sharma; L Savy; J Britton; R Taylor; A Howick; M Patton
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-02       Impact factor: 10.154

5.  New mutation to Huntington's disease.

Authors:  G Wolff; G Deuschl; T F Wienker; K Hummel; K Bender; C H Lücking; M Schumacher; J Hammer; G Oepen
Journal:  J Med Genet       Date:  1989-01       Impact factor: 6.318

6.  Reduced regional cerebral blood flow in Huntington's disease studied by SPECT.

Authors:  S G Hasselbalch; G Oberg; S A Sørensen; A R Andersen; G Waldemar; J F Schmidt; K Fenger; O B Paulson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-11       Impact factor: 10.154

7.  Is direct CT caudatometry superior to indirect parameters in confirming Huntington's disease?

Authors:  C Lang
Journal:  Neuroradiology       Date:  1985       Impact factor: 2.804

8.  Huntington's disease in a Sudanese family from Khartoum.

Authors:  E M Scrimgeour; Y Samman; D J Brock
Journal:  Hum Genet       Date:  1995-11       Impact factor: 4.132

9.  Imaging of cerebral blood flow markers in Huntington's disease using single photon emission computed tomography.

Authors:  I C Reid; J A Besson; P V Best; P F Sharp; H G Gemmell; F W Smith
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-10       Impact factor: 10.154

Review 10.  3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington's disease: past, present and future.

Authors:  Isaac Túnez; Inmaculada Tasset; Verónica Pérez-De La Cruz; Abel Santamaría
Journal:  Molecules       Date:  2010-02-10       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.